Brokerages Set Diploma PLC (LON:DPLM) PT at GBX 5,365

Diploma PLC (LON:DPLM) has received a consensus rating of “Moderate Buy” from the six analysts that are presently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is GBX 5,365.

A number of brokerages have issued reports on DPLM. Shore Capital reaffirmed a “hold” rating and issued a GBX 5,100 target price on shares of Diploma in a report on Thursday, July 17th. Berenberg Bank raised their price objective on shares of Diploma from GBX 5,750 to GBX 6,350 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. JPMorgan Chase & Co. reissued a “neutral” rating and set a GBX 4,440 price objective on shares of Diploma in a research note on Wednesday, August 6th. Jefferies Financial Group raised their price objective on shares of Diploma from GBX 4,500 to GBX 5,200 and gave the stock a “hold” rating in a research note on Thursday, September 11th. Finally, Royal Bank Of Canada raised shares of Diploma to an “outperform” rating and raised their price objective for the stock from GBX 4,500 to GBX 6,000 in a research note on Friday, October 3rd.

Diploma Trading Down 1.7%

Shares of Diploma stock opened at GBX 5,505 on Tuesday. Diploma has a 12-month low of GBX 3,532 and a 12-month high of GBX 5,700. The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17. The stock has a market cap of £7.38 billion, a PE ratio of 44.29, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The company has a 50-day moving average of GBX 5,421.45 and a two-hundred day moving average of GBX 4,997.03.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.